MCID: PNC056
MIFTS: 50

Pineocytoma

Categories: Cancer diseases, Endocrine diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Pineocytoma

MalaCards integrated aliases for Pineocytoma:

Name: Pineocytoma 53 59 55 73
Tumor of the Pineal Region 73
Pineal Gland Neoplasm 73
Pinealocytoma 53
Pinealoma 53

Classifications:

Orphanet: 59  
Rare neurological diseases


External Ids:

Orphanet 59 ORPHA251912
UMLS via Orphanet 74 C0917890
ICD10 via Orphanet 34 D44.5

Summaries for Pineocytoma

NIH Rare Diseases : 53 A pineocytoma is a tumor of the pineal gland, a small organ in the brain that makes melatonin (a sleep-regulating hormone). Pineocytomas most often occur in adults as a solid mass, although they may appear to have fluid-filled (cystic) spaces on images of the brain. Signs and symptoms of pineocytomas include headaches, nausea, hydrocephalus, vision abnormalities, and Parinaud syndrome. Pineocytomas are usually slow-growing and rarely spread to other parts of the body. Treatment includes surgery to remove the pineocytoma; most of these tumors do not regrow (recur) after surgery.

MalaCards based summary : Pineocytoma, also known as tumor of the pineal region, is related to pineoblastoma and pineal gland cancer. An important gene associated with Pineocytoma is ASMT (Acetylserotonin O-Methyltransferase), and among its related pathways/superpathways are Neuroscience and Neural Stem Cell Differentiation Pathways and Lineage-specific Markers. The drugs Melphalan and Carboplatin have been mentioned in the context of this disorder. Affiliated tissues include pineal, brain and bone, and related phenotypes are hydrocephalus and nystagmus

Wikipedia : 76 Pineocytoma, also known as a pinealocytoma, is a benign, slowly growing tumor of the pineal gland.... more...

Related Diseases for Pineocytoma

Diseases related to Pineocytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 214)
# Related Disease Score Top Affiliating Genes
1 pineoblastoma 32.1 ASMT GFAP SAG SYP
2 pineal gland cancer 31.0 ASMT ENO2 GFAP SAG SYP TUBB3
3 teratoma 29.8 ENO2 GFAP SYP
4 pineal parenchymal tumor of intermediate differentiation 29.3 ASMT ENO2 RHO SAG SYP TUBB3
5 purulent endophthalmitis 10.2 SAG SYP
6 ectopic cushing syndrome 10.2 S100B SYP
7 tracheoesophageal fistula 10.2 S100B SYP
8 ovarian carcinosarcoma 10.2 SYP TUBB3
9 giant cell glioblastoma 10.2 GFAP SYP
10 childhood oligodendroglioma 10.2 GFAP SYP
11 cerebellopontine angle tumor 10.2 GFAP SYP
12 pilomyxoid astrocytoma 10.2 GFAP SYP
13 meningioma, radiation-induced 10.2 GFAP S100B
14 myoepithelioma 10.2 GFAP S100B
15 anterior cranial fossa meningioma 10.2 CHGA SYP
16 pulmonary blastoma 10.2 CHGA SYP
17 tubular adenocarcinoma 10.2 CHGA SYP
18 gastric tubular adenocarcinoma 10.2 CHGA SYP
19 non-functioning pancreatic endocrine tumor 10.2 CHGA SYP
20 desmoplastic infantile ganglioglioma 10.2 GFAP SYP
21 extraventricular neurocytoma 10.2 GFAP SYP
22 lung combined type small cell carcinoma 10.2 GFAP SYP
23 panophthalmitis 10.2 SAG SYP
24 mixed type thymoma 10.2 S100B SYP
25 chondroid chordoma 10.2 ENO2 TUBB3
26 hypoganglionosis 10.2 S100B SYP
27 ureter small cell carcinoma 10.2 CHGA SYP
28 esophageal neuroendocrine tumor 10.2 CHGA SYP
29 ovarian large-cell neuroendocrine carcinoma 10.1 CHGA SYP
30 rosette-forming glioneuronal tumor 10.1 S100B SYP
31 chondrosarcoma, extraskeletal myxoid 10.1 ENO2 SYP
32 bone benign neoplasm 10.1 ENO2 SYP
33 connective tissue benign neoplasm 10.1 ENO2 SYP
34 mixed cell type cancer 10.1 ENO2 SYP
35 adrenal rest tumor 10.1 ENO2 SYP
36 glomus tumor 10.1 ENO2 SYP
37 mucinous ovarian cystadenoma 10.1 ENO2 SYP
38 optic nerve neoplasm 10.1 ENO2 SYP
39 adenoma of the pancreas 10.1 CHGA SYP
40 intraocular retinoblastoma 10.1 ENO2 SYP
41 basaloid squamous cell carcinoma 10.1 ENO2 SYP
42 prostate small cell carcinoma 10.1 ENO2 SYP
43 acinar cell cystadenocarcinoma 10.1 CHGA SYP
44 meningeal melanomatosis 10.1 ENO2 SYP
45 extraskeletal ewing sarcoma 10.1 ENO2 SYP
46 peritoneal serous adenocarcinoma 10.1 CHGA SYP
47 chiari malformation 10.1 GFAP SYP
48 gemistocytic astrocytoma 10.1 GFAP S100B
49 gastrointestinal neuroendocrine tumor 10.1 CHGA SYP
50 syringocystadenoma papilliferum 10.1 GFAP S100B

Graphical network of the top 20 diseases related to Pineocytoma:



Diseases related to Pineocytoma

Symptoms & Phenotypes for Pineocytoma

Human phenotypes related to Pineocytoma:

59 32 (show all 14)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 hydrocephalus 59 32 hallmark (90%) Very frequent (99-80%) HP:0000238
2 nystagmus 59 32 frequent (33%) Frequent (79-30%) HP:0000639
3 nausea and vomiting 59 32 hallmark (90%) Very frequent (99-80%) HP:0002017
4 increased intracranial pressure 59 32 hallmark (90%) Very frequent (99-80%) HP:0002516
5 hearing abnormality 59 32 occasional (7.5%) Occasional (29-5%) HP:0000364
6 memory impairment 59 32 hallmark (90%) Very frequent (99-80%) HP:0002354
7 difficulty walking 59 32 occasional (7.5%) Occasional (29-5%) HP:0002355
8 headache 59 32 hallmark (90%) Very frequent (99-80%) HP:0002315
9 increased csf protein 59 32 frequent (33%) Frequent (79-30%) HP:0002922
10 episodic ataxia 59 32 frequent (33%) Frequent (79-30%) HP:0002131
11 altitudinal visual field defect 59 32 frequent (33%) Frequent (79-30%) HP:0030531
12 cognitive impairment 59 Frequent (79-30%)
13 abnormality of the eyelid 59 Frequent (79-30%)
14 abnormal eyelid morphology 32 frequent (33%) HP:0000492

MGI Mouse Phenotypes related to Pineocytoma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 nervous system MP:0003631 9.23 AANAT CHGA ENO2 GFAP RHO SAG

Drugs & Therapeutics for Pineocytoma

Drugs for Pineocytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 172)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Melphalan Approved Phase 2, Phase 3,Phase 1 148-82-3 4053 460612
2
Carboplatin Approved Phase 2, Phase 3,Phase 1,Not Applicable 41575-94-4 10339178 38904 498142
3
Thiotepa Approved, Investigational Phase 2, Phase 3,Not Applicable 52-24-4 5453
4
Cyclophosphamide Approved, Investigational Phase 2, Phase 3,Not Applicable 6055-19-2, 50-18-0 2907
5
Etoposide Approved Phase 2, Phase 3,Phase 1,Not Applicable 33419-42-0 36462
6
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
7
Donepezil Approved Phase 3,Phase 2 120014-06-4 3152
8
Lenograstim Approved, Investigational Phase 3,Phase 2,Phase 1 135968-09-1
9 Pancreatic Polypeptide Investigational Phase 3,Phase 1 59763-91-6
10 Etoposide phosphate Phase 2, Phase 3,Phase 1,Not Applicable
11 Cola Phase 3,Phase 1
12 Central Nervous System Depressants Phase 3,Phase 2
13 Adjuvants, Anesthesia Phase 3
14 Liver Extracts Phase 3,Phase 1,Phase 2
15 Anesthetics, Intravenous Phase 3
16 Analgesics, Opioid Phase 3
17 Peripheral Nervous System Agents Phase 3,Phase 2,Phase 1
18 Anesthetics, General Phase 3
19 Analgesics Phase 3,Phase 2,Phase 1
20 Narcotics Phase 3
21 Anesthetics Phase 3
22 Neurotransmitter Agents Phase 3,Phase 2
23 Nootropic Agents Phase 3,Phase 2
24 Cholinergic Agents Phase 3,Phase 2
25 Cholinesterase Inhibitors Phase 3,Phase 2
26 Immunologic Factors Phase 3,Phase 2,Phase 1,Not Applicable
27 Adjuvants, Immunologic Phase 3,Phase 1
28
Bevacizumab Approved, Investigational Phase 2 216974-75-3
29 Piracetam Approved, Investigational Phase 2 7491-74-9
30
Pregabalin Approved, Illicit, Investigational Phase 2 148553-50-8 5486971
31
Temozolomide Approved, Investigational Phase 1, Phase 2,Phase 2 85622-93-1 5394
32
Dacarbazine Approved, Investigational Phase 1, Phase 2,Phase 2 4342-03-4 5351166
33
Sirolimus Approved, Investigational Phase 2,Phase 1 53123-88-9 46835353 6436030 5284616
34
Irinotecan Approved, Investigational Phase 2,Phase 1 100286-90-6, 97682-44-5 60838
35
Everolimus Approved Phase 2,Phase 1 159351-69-6 6442177
36
Miconazole Approved, Investigational, Vet_approved Phase 2,Phase 1 22916-47-8 4189
37 tannic acid Approved Phase 2
38
Dasatinib Approved, Investigational Phase 2,Phase 1 302962-49-8 3062316
39
Ethanol Approved Phase 2 64-17-5 702
40
Benzocaine Approved, Investigational Phase 2 94-09-7, 1994-09-7 2337
41
Titanium dioxide Approved Phase 2 13463-67-7
42
Sorbitol Approved Phase 2 50-70-4 5780
43
Ifosfamide Approved Phase 1, Phase 2 3778-73-2 3690
44
Mechlorethamine Approved, Investigational Phase 1, Phase 2,Phase 2 51-75-2 4033
45
Mannitol Approved, Investigational Phase 1, Phase 2 69-65-8 453 6251
46
Vitamin C Approved, Nutraceutical Phase 2 50-81-7 5785 54670067
47 Etiracetam Investigational Phase 2 33996-58-6
48
Camptothecin Experimental Phase 1, Phase 2,Phase 2 7689-03-4
49 Photosensitizing Agents Phase 2,Phase 1
50 Dermatologic Agents Phase 2,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 65)
# Name Status NCT ID Phase Drugs
1 Stem Cell Transplant for High Risk Central Nervous System (CNS) Tumors Unknown status NCT00179803 Phase 2, Phase 3
2 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
3 Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors Completed NCT00369785 Phase 3 donepezil hydrochloride;Placebo
4 Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer Active, not recruiting NCT01987596 Phase 3
5 Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas Unknown status NCT01024907 Phase 1, Phase 2
6 Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors Completed NCT00025077 Phase 2 carboplatin;cyclophosphamide;thiotepa
7 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed NCT00492089 Phase 2 bevacizumab;placebo
8 Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors Completed NCT00629889 Phase 2 levetiracetam;pregabalin
9 Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor Completed NCT00070161 Phase 2 donepezil hydrochloride
10 Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Tumors Completed NCT00003461 Phase 1, Phase 2
11 Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma Completed NCT01977677 Phase 1, Phase 2 temozolomide;plerixafor
12 Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma Recruiting NCT02596828 Phase 2 Temozolomide;Irinotecan;Dasatinib;Rapamycin
13 Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors Recruiting NCT02095132 Phase 1, Phase 2 Adavosertib;Irinotecan Hydrochloride
14 Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Active, not recruiting NCT01217437 Phase 2 Irinotecan Hydrochloride;Temozolomide
15 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors Active, not recruiting NCT00788125 Phase 1, Phase 2 carboplatin;dasatinib;etoposide phosphate;ifosfamide
16 Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors Suspended NCT00983398 Phase 1, Phase 2 Carboplatin;Mannitol;Melphalan;Sodium Thiosulfate
17 Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors Unknown status NCT00002647 Phase 1 verteporfin
18 Stereotactic Radiosurgery in Treating Patients With Brain Tumors Completed NCT00019578 Phase 1
19 RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma Completed NCT01119599 Phase 1 Gamma-Secretase Inhibitor RO4929097;Temozolomide
20 A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors Completed NCT00784914 Phase 1 temsirolimus
21 Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment Completed NCT00544284 Phase 1 bortezomib;temozolomide
22 Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer Completed NCT00006368 Phase 1
23 Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors Completed NCT00008086 Phase 1 carboplatin
24 Thalidomide and Docetaxel in Treating Patients With Advanced Cancer Completed NCT00049296 Phase 1 docetaxel;thalidomide
25 Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas Completed NCT00019019 Phase 1 carboxyamidotriazole;paclitaxel
26 Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors Completed NCT00019630 Phase 1 doxorubicin HCl liposome
27 Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma Completed NCT01273090 Phase 1 imetelstat sodium
28 PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors Completed NCT01158300 Phase 1 VEGF inhibitor PTC299
29 Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors Completed NCT00003484 Phase 1 carmustine;irinotecan hydrochloride
30 MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma Completed NCT00020579 Phase 1 entinostat
31 Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Completed NCT01076530 Phase 1 vorinostat;temozolomide
32 Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Completed NCT00994500 Phase 1 vorinostat;bortezomib
33 ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors Completed NCT00946335 Phase 1 veliparib;temozolomide
34 AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors Completed NCT00326664 Phase 1 Cediranib Maleate
35 Lenalidomide in Treating Young Patients With Recurrent, Progressive, or Refractory CNS Tumors Completed NCT00100880 Phase 1 lenalidomide
36 Cilengitide in Treating Children With Refractory Primary Brain Tumors Completed NCT00063973 Phase 1 cilengitide
37 Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors Completed NCT00052780 Phase 1 O6-benzylguanine;temozolomide
38 SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors Recruiting NCT03434262 Phase 1 Gemcitabine;ribociclib;sonidegib;trametinib
39 Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors Recruiting NCT02780804 Phase 1 Entinostat
40 EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors Recruiting NCT03638167 Phase 1
41 HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors Recruiting NCT03500991 Phase 1
42 Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors Recruiting NCT02255461 Phase 1 palbociclib isethionate
43 Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor Active, not recruiting NCT00638898 Phase 1 busulfan;melphalan;topotecan hydrochloride
44 Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors Terminated NCT00110032 Phase 1 EF5
45 Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Terminated NCT01088763 Phase 1 gamma-secretase/Notch signalling pathway inhibitor RO4929097;dexamethasone
46 A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Withdrawn NCT01182883 Phase 1 IMC-A12;Temsirolimus
47 Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom Unknown status NCT00757614
48 Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging Completed NCT01884194
49 Study of Blood and Cheek Cell Samples From Patients With Glioma Completed NCT01009307
50 Study of Tissue Samples From Patients With Glioma or Other Brain Tumors Completed NCT00967200

Search NIH Clinical Center for Pineocytoma

Genetic Tests for Pineocytoma

Anatomical Context for Pineocytoma

MalaCards organs/tissues related to Pineocytoma:

41
Pineal, Brain, Bone, Lung, Liver, Ovary, Cervix

Publications for Pineocytoma

Articles related to Pineocytoma:

(show top 50) (show all 119)
# Title Authors Year
1
Papillary tumor of the pineal region: Case report and review of the literature. ( 29691144 )
2018
2
Papillary tumor of the pineal region in children: presentation of a case and comprehensive literature review. ( 29906576 )
2018
3
Papillary tumor of the pineal region accompanied by Parinaud's syndrome: magnetic resonance imaging findings. ( 29991845 )
2018
4
Recurrent Pineocytomalike Papillary Tumor of The Pineal Region: A Case Report and Literature Review. ( 30165231 )
2018
5
Durable response to mTOR inhibition in a patient with relapsing papillary tumor of the pineal region. ( 30295836 )
2018
6
Therapeutic strategy for pineal parenchymal tumor of intermediate differentiation (PPTID): case report of PPTID with malignant transformation to pineocytoma with leptomeningeal dissemination 6 years after surgery. ( 30028263 )
2018
7
Masson's tumor of the pineal region: case report. ( 28777021 )
2018
8
A Case of Nongerminomatous Germ Cell Tumor of the Pineal Region: Risks and Advantages of Biopsy by Endoscopic Approach. ( 29713348 )
2018
9
Nuclear CRX and FOXJ1 Expression Differentiates Non-Germ Cell Pineal Region Tumors and Supports the Ependymal Differentiation of Papillary Tumor of the Pineal Region. ( 28719464 )
2017
10
Papillary Tumor of the Pineal Region: A Distinct Molecular Entity. ( 26113311 )
2016
11
Late dissemination via cerebrospinal fluid of papillary tumor of the pineal region: a case report and literature review. ( 27179224 )
2016
12
Increased VEGF levels in one case of papillary tumor of the pineal region with intracranial haemorrhage at presentation: a potential surrogate indicator of tumor angiogenesis and aggressiveness? ( 26745494 )
2016
13
Cytologic features of papillary tumor of the pineal region: A case report showing tigroid background. ( 27535020 )
2016
14
A case of papillary tumor of the pineal region with a long clinical history: molecular characterization and therapeutic consideration with review of the literature. ( 27472995 )
2016
15
Atypical Teratoid/Rhabdoid Tumor of the Pineal Region in a Young Adult Male Patient: Case Report and Review of the Literature. ( 27144539 )
2016
16
Progressive supranuclear palsy motor phenotype in a patient with pineocytoma. ( 27432179 )
2016
17
Long-term follow-up of a papillary tumor of the pineal region: addendum to a case report. ( 27568037 )
2016
18
Papillary tumor of the pineal region with extended clinical and radiologic follow-up. ( 26539320 )
2015
19
Lack of BRAF-V600E Mutation in Papillary Tumor of the Pineal Region. ( 26125673 )
2015
20
Papillary tumor of the pineal region-report of three cases with literature review. ( 26238893 )
2015
21
Papillary tumor of the pineal region presenting with Foster Kennedy sign. ( 26183673 )
2015
22
Papillary tumor of the pineal region: A case report and review of the literature. ( 26622493 )
2015
23
Papillary tumor of the pineal region: Histopathological characterization and review of the literature. ( 24556386 )
2015
24
Papillary tumor of the pineal region with synchronous suprasellar focus and novel cytogenetic features. ( 26068071 )
2015
25
Outcomes After Surgery and Radiotherapy for Papillary Tumor of the Pineal Region. ( 25749579 )
2015
26
Papillary Tumor of the Pineal Region: MR Signal Intensity Correlated to Histopathology. ( 25688307 )
2015
27
Papillary tumor of the pineal region. Report of two cases and literature review. ( 25440015 )
2014
28
Stereotactic radiosurgery of a papillary tumor of the pineal region: case report and review of the literature. ( 23446182 )
2013
29
Bevacizumab is Effective for Recurrent Papillary Tumor of the Pineal Region: First Report. ( 24019784 )
2013
30
Papillary tumor of the pineal region with anaplastic small cell component. ( 23817812 )
2013
31
Papillary tumor of the pineal region: a case involving isocitrate dehydrogenase (IDH) genotyping. ( 22466620 )
2013
32
Early treatment response of a rare papillary tumor of the pineal region after primary proton-beam therapy using the raster-scanning technique at HIT. ( 23235766 )
2012
33
Sleep disturbance after pinealectomy in patients with pineocytoma WHOA^I. ( 22706841 )
2012
34
Familial pineocytoma. ( 22699425 )
2012
35
Complete regression of papillary tumor of the pineal region after radiation therapy: case report and review of the literature. ( 22086239 )
2012
36
Four-year clinical and neuroradiological follow-up of a papillary tumor of the pineal region. ( 22124853 )
2012
37
Papillary tumor of the pineal region. ( 22275792 )
2012
38
Papillary tumor of the pineal region: ultrastructural study of a case. ( 22292738 )
2012
39
Pleomorphic pineocytoma associated with normal pineal parenchyma: report of a case in a 70-year-old man. ( 20573029 )
2011
40
Pineocytoma in a lowland anoa (Bubalus depressicornis). ( 20961555 )
2011
41
Contemporary management of pineocytoma. ( 21801989 )
2011
42
Pineocytoma with diffuse dissemination to the leptomeninges. ( 22355508 )
2011
43
Spinal metastasis of papillary tumor of the pineal region. ( 21109346 )
2011
44
Papillary tumor of the pineal region in a 15-month-old boy. ( 21529195 )
2011
45
Papillary tumor of the pineal region. ( 21629978 )
2011
46
Adjuvant temozolomide chemotherapy for treatment of papillary tumor of the pineal region. ( 21839968 )
2011
47
Papillary tumor of the pineal region: two case studies and a review of the literature. ( 21844577 )
2011
48
Atypical teratoid/rhabdoid tumor of the pineal region in an adult. ( 19911885 )
2010
49
Tumor control after surgery and radiotherapy for pineocytoma. ( 20136388 )
2010
50
Factors influencing overall survival rates for patients with pineocytoma. ( 20461445 )
2010

Variations for Pineocytoma

Expression for Pineocytoma

Search GEO for disease gene expression data for Pineocytoma.

Pathways for Pineocytoma

GO Terms for Pineocytoma

Cellular components related to Pineocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 photoreceptor inner segment GO:0001917 8.8 ENO2 RHO SAG

Biological processes related to Pineocytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 response to light stimulus GO:0009416 9.37 AANAT RHO
2 regulation of rhodopsin mediated signaling pathway GO:0022400 9.32 RHO SAG
3 regulation of neuronal synaptic plasticity GO:0048168 9.26 S100B SYP
4 rhodopsin mediated signaling pathway GO:0016056 9.16 RHO SAG
5 indolalkylamine biosynthetic process GO:0046219 8.96 AANAT ASMT
6 melatonin biosynthetic process GO:0030187 8.62 AANAT ASMT

Sources for Pineocytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....